GreenLight and US NIH partner to develop Covid-19 vaccine for variants
The parties aim to manufacture vaccines with lasting immune responses compared to existing ones.
News
Latest in
News
Moderna signs contract to supply Covid-19 booster vaccines to the US
The initial 66 million vaccine doses are anticipated to be supplied this year.
Can a nasal spray tackle agitation in autism?
Despite the need, children with autism spectrum disorder are left with few difficult-to-administer off-label medications to treat agitation.
By
CAMP4’s $100m Series B backs regulatory RNA-led efforts in urea cycle disorders
CAMP4 Therapeutics’ $100 million Series B supports clinical trial plans for urea cycle disorder program in 2023.
By
Pfizer reports 53% operational growth in Q2 2022 revenues
In Q2 2022, the reported diluted EPS stood at $1.73 as against $0.98 in the year-ago quarter, indicating a 77%…
FDA accepts to review ImmunityBio’s BLA for bladder cancer treatment
The BLA is based on positive data from various studies of N-803, including the Phase II/III QUILT 3.032 trial.
Novartis and UC Berkeley partner to discover new treatments
The alliance intends to unlock intractable drug targets and discover new therapies for human diseases.
BMS reports 2% rise in total revenue in Q2 2022
Revenues grew 12% to $8.3bn in the US for the three months ended on 30 June.